AI Drug Development Startups Raised $2.1B in H1 2021Ulrik Kristensen2021-11-19T16:54:52+00:00July 6th, 2021|
The Science Advisory Board: Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-06-07T13:49:03+01:00June 7th, 2021|
Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-11-19T16:56:28+00:00May 27th, 2021|
Charles River Acquired Distributed Bio – Here’s What it Means for the AI EcosystemUlrik Kristensen2021-11-19T16:58:49+00:00January 14th, 2021|
Featured in The Science Advisory Board: How is the pharma-AI partnership landscape changing?Ulrik Kristensen2021-06-07T13:51:22+01:00January 12th, 2021|
Featured in Yahoo Finance: AI Drug Development Investments Accelerated in 2020Ulrik Kristensen2021-04-20T12:57:10+01:00December 31st, 2020|
